Paris, France

Quantum Genomics


USPTO Granted Patents = 7

% Expired Patents = 71.4


Forward Citations = 1

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Fabrice Balavoine (7 out of 9 patents)

silverMedal Jean-Marie Schneider (4 out of 10 patents)

bronzeMedal Nicolas Couvrat (4 out of 4 patents)

4.  Catherine Llorens-Cortes (3 out of 6 patents)

5.  Yannick Marc (3 out of 3 patents)

6.  Gérard Coquerel (3 out of 13 patents)

7.  Delphine Compere (2 out of 8 patents)

8.  Jonathan Madec (2 out of 6 patents)

9.  Yohann Cartigny (2 out of 3 patents)

10.  Mathilde Keck (1 out of 1 patent)

11.  Solène E Boitard (1 out of 1 patent)

12.  Gerard Coquerel (1 out of 18 patents)

13.  Marie-Noelle Petit (1 out of 4 patents)

14.  Ji Gao-Desliens (1 out of 1 patent)

15.  Lionel Segard (1 out of 1 patent)


7 patents:

Quantum Genomics is a biopharmaceutical company specializing in the development of new treatments for hypertension and heart failure. Their innovative approach targets the brain renin-angiotensin system to regulate blood pressure. With a strong focus on research and development, Quantum Genomics is at the forefront of cutting-edge therapies for cardiovascular diseases.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

7 Patents

#451 in Paris

#2,218 in France

Paris, FR
Paris, France
Forward Citations = 1

16 inventors:

Please report any incorrect information to [email protected]
Loading…